|
GNPDA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62625468647093E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09801057135428E-13 |
| Normal-vs-Stage2 |
1.08119999997491E-06 |
| Normal-vs-Stage3 |
1.61019975131182E-10 |
| Normal-vs-Stage4 |
1.00010000281259E-11 |
| Stage1-vs-Stage2 |
8.132600E-01 |
| Stage1-vs-Stage3 |
3.849200E-01 |
| Stage1-vs-Stage4 |
1.761530E-02 |
| Stage2-vs-Stage3 |
4.679000E-01 |
| Stage2-vs-Stage4 |
8.119900E-02 |
| Stage3-vs-Stage4 |
1.987010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
1.388020E-04 |
| Normal-vs-Asian |
3.93480004134972E-09 |
| Caucasian-vs-AfricanAmerican |
5.590400E-01 |
| Caucasian-vs-Asian |
9.874000E-01 |
| AfricanAmerican-vs-Asian |
6.357200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03184127908662E-12 |
| Normal-vs-Female |
1.69853020537403E-12 |
| Male-vs-Female |
5.593000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.56838994516784E-12 |
| Normal-vs-Age(41-60Yrs) |
1.85129689356245E-11 |
| Normal-vs-Age(61-80Yrs) |
6.74309497128434E-11 |
| Normal-vs-Age(81-100Yrs) |
6.056300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.245600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.457600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.521400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.092400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.188600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.980600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.278100E-02 |
| Classical-VS-Follicular |
1.612400E-01 |
| Classical-VS-Other |
5.057200E-01 |
| Classical-VS-Normal |
3.92989996100823E-09 |
| Tall-VS-Follicular |
7.296300E-03 |
| Tall-VS-Other |
8.001600E-01 |
| Tall-VS-Normal |
3.8754000009078E-10 |
| Follicular-VS-Other |
3.490400E-01 |
| Follicular-VS-Normal |
1.52647999999145E-05 |
| Other-VS-Normal |
3.556800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.13810080751387E-11 |
| Normal-vs-N1 |
1.49239953728397E-10 |
| N0-vs-N1 |
6.187800E-02 |
|
|
